High serum fibroblast growth factor 21 is associated with inferior hepatocellular carcinoma survival: A prospective cohort study.
Zhao-Yan LiuYan LuoAi-Ping FangMaierhaba WusimanTong-Tong HeXiao-Zhan LiuDinuerguli YishakeSi ChenXiao-Ting LuYao-Jun ZhangHui-Lian ZhuPublished in: Liver international : official journal of the International Association for the Study of the Liver (2021)
Higher serum FGF21 levels were associated with worse survival in HCC patients, suggesting that serum FGF21 may be used as a novel metabolism-related prognostic biomarker for HCC.